Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Other Operating Expenses: 2011-2025

Historic Other Operating Expenses for Abeona Therapeutics (ABEO) over the last 11 years, with Sep 2025 value amounting to $488,000.

  • Abeona Therapeutics' Other Operating Expenses was N/A to $488,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $540,000 for FY2023, which is 91.16% down from last year.
  • Per Abeona Therapeutics' latest filing, its Other Operating Expenses stood at $488,000 for Q3 2025, which was up 388.00% from $100,000 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Other Operating Expenses ranged from a high of $32.5 million in Q4 2021 and a low of -$1.1 million during Q2 2022.
  • In the last 2 years, Abeona Therapeutics' Other Operating Expenses had a median value of $403,000 in 2023 and averaged $306,200.
  • In the last 5 years, Abeona Therapeutics' Other Operating Expenses crashed by 733.33% in 2022 and then spiked by 6,816.67% in 2023.
  • Over the past 4 years, Abeona Therapeutics' Other Operating Expenses (Quarterly) stood at $32.5 million in 2021, then tumbled by 96.77% to $1.1 million in 2022, then surged by 257.89% to $30,000 in 2023, then reached $488,000 in 2025.
  • Its Other Operating Expenses stands at $488,000 for Q3 2025, versus $100,000 for Q2 2025 and $30,000 for Q3 2023.